Impact of Regulatory Interventions on Ulipristal Acetate 5 mg (Esmya) Use in Spain: An Interrupted Time-Series Analysis.
Marta Monreal-Di BelloDiana González-BermejoBelén Castillo-CanoAlfonso Rodriguez-PascualDolores Montero-CorominasPublished in: Pharmacoepidemiology and drug safety (2024)
Despite RMM had an immediate strong impact on UPA use, the last segment upward trend in the long-term might have been affected by the lack of comparable therapeutic alternatives. Further studies should be performed to confirm the increase trend observed and analyze subsequent measures and additional data.